251 related articles for article (PubMed ID: 34965522)
1. Targeted drug delivery vehicles mediated by nanocarriers and aptamers for posterior eye disease therapeutics: barriers, recent advances and potential opportunities.
Zhang T; Jin X; Zhang N; Jiao X; Ma Y; Liu R; Liu B; Li Z
Nanotechnology; 2022 Jan; 33(16):. PubMed ID: 34965522
[TBL] [Abstract][Full Text] [Related]
2. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-guided nanomedicines for anticancer drug delivery.
Alshaer W; Hillaireau H; Fattal E
Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
[TBL] [Abstract][Full Text] [Related]
4. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
5. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
6. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
8. Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease.
Faria MJ; González-Méijome JM; Real Oliveira MECD; Carracedo G; Lúcio M
Adv Drug Deliv Rev; 2024 Jul; 210():115321. PubMed ID: 38679293
[TBL] [Abstract][Full Text] [Related]
9. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
[TBL] [Abstract][Full Text] [Related]
11. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
Srinivasarao DA; Lohiya G; Katti DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
[TBL] [Abstract][Full Text] [Related]
12. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
[TBL] [Abstract][Full Text] [Related]
13. Ocular drug delivery: nanomedicine applications.
Vandervoort J; Ludwig A
Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
[TBL] [Abstract][Full Text] [Related]
14. Nanotherapy for posterior eye diseases.
Kaur IP; Kakkar S
J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
[TBL] [Abstract][Full Text] [Related]
15. Synthetic nanocarriers for the delivery of polynucleotides to the eye.
Saraiva SM; Castro-López V; Pañeda C; Alonso MJ
Eur J Pharm Sci; 2017 May; 103():5-18. PubMed ID: 28263915
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.
Fu Z; Xiang J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266216
[TBL] [Abstract][Full Text] [Related]
17. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs.
Hashemi M; Shamshiri A; Saeedi M; Tayebi L; Yazdian-Robati R
Arch Biochem Biophys; 2020 Sep; 691():108485. PubMed ID: 32712288
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
Zhu H; Li J; Zhang XB; Ye M; Tan W
ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery to the eye: what benefits do nanocarriers offer?
Joseph RR; Venkatraman SS
Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
[TBL] [Abstract][Full Text] [Related]
20. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
